Lilly - Biotech, Pharma and Life Science Channel
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Approximatly one fifth of these are dedicated to R&D. Its products are also marketed over a wide global market, covering 143 countries.
Their major recently produced products include Axiron (male hormone replacement therapy), Livalo (treatment for hyperlipidemaia) and Adcirca (for pulmonary arterial hypertension). The main categories for therapeutic medications are cancer, cardiology/pulmonary, diabetes, men's health, fibromyalgia, growth disorders, neuroscience, osteoposisis and sepesis.
Source; BioPortfolio.com and Lilly.com
Add the Lilly News Channel to your RSS reader;
Follow the Lilly Twitter feed;
News Articles
Corgenix Announces Diagnostic Development Agreement with Lilly
-- Companies to focus on potential companion diagnostic opportunity -- Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test...
Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of...
INDIANAPOLIS, May 20, 2013 /PRNewswire/ -- The many health care providers working at Eli Lilly and Company (NYSE:LLY) − including doctors, nurses, and pharmacists − play a vital role in br...
Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
NEW YORK, NY -- (Marketwired) -- 05/20/13 -- The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology compani...
Lilly Oncology to Release New Pipeline Data at ASCO 2013
INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49th Annual Meeting of the...
Third Rock Ventures Expands and Strengthens Team
Third Rock Ventures, LLC, a venture capital firm focused on building healthcare companies, today announced that it has expanded and strengthened its team with several appoi...
Lilly Provides Update on CEO Dr. John Lechleiter
INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, underwent scheduled s...
INDIANAPOLIS, May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monothe...
RIDGEFIELD, Conn. and INDIANAPOLIS, May 6, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from two new pooled analys...
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
INDIANAPOLIS, May 6, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, will undergo scheduled...
Events
None
Companies
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer...
Nimbus Discovery, a biotechnology company, harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically i...
Indianapolis-based YourEncore accelerates innovation and growth for companies in the life sciences, food and consumer product industries. The companyâs 7,000+ veteran-level e...
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forwardâs products and services have been utilized in o...
Aircuity is the smart airside efficiency company providing building owners with sustained energy savings through its intelligent measurement solutions. By combining real-time sens...
Berlin-based NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers® for the treatment of inflammatory diseases and hematological...
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 1...
Deltagen, Inc. is a leading provider of drug discovery tools to the biopharmaceutical industry. Deltagen offers access to its extensive inventory of knockout mouse lines and relat...
Flexion Therapeutics in-licenses clinically enabled drug candidates with high-value specialty potential and develops these to proof of concept (PoC) and beyond. The independent co...
Receptos is a biopharmaceutical company developing best- and first-in-class G protein-coupled receptor (GPCR) therapeutic candidates through information-driven drug discovery, inc...
Clinical Trials
This is a Phase II study of gemcitabine- Vinorelbine combination in a 3-weekly schedule as first line chemotherapy in patients with metastatic breast cancer. Eighty patients with measurabl...
An Open Label Study of Oral Enzastaurin in Patients With Cancer
This study will collect further basic safety data on patients with cancer treated with enzastaurin. This study is not open to the public. The purpose of the this study is to extend the c...
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
Parathyroid hormone (PTH) has potent bone-building actions and has been approved for the treatment of osteoporosis as FORTEO by Eli Lilly & Co. Numerous studies have verified its effectiv...
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
We propose to develop novel diagnostic tests for severe sepsis and community acquired pneumonia (CAP). This program, entitled Community Acquired Pneumonia & Sepsis Outcome Diagnostics (CAP...
Inpatient Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Mania: This study recruits adult subjects who are diagnosed with Bip...
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Phase 3 , open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected insulin in type 1 and type 2 diabetes patients...
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
This is a phase 3, open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected pre-meal insulin in non-smoking patien...
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Lilly's Emotional and Physical Symptoms of Depression
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Lilly's Emotional and Physical Symptoms of Depression Study
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting
PubMed Articles
Cross-ratio estimation for bivariate failure times with left truncation.
The cross-ratio is an important local measure that characterizes the dependence between bivariate failure times. To estimate the cross-ratio in follow-up studies where delayed entry is present, estima...
This study demonstrates the use of hydrophilic interaction liquid chromatography with a nano quantity analyte detector for the retention, separation and detection of magnesium from magnesium stearate...
In this work, a high performance liquid chromatography (HPLC) method is reported for the separation and quantitation of a drug substance that is highly polar and lacking a chromophore in a mannitol in...
The aim of this qualitative analysis was to establish the content validity of two new patient-reported outcome (PRO) measures, Confidence in Performing Sexual Intercourse Questionnaire (CPSIQ) and Dif...
Single nucleotide polymorphisms in six genes were investigated for an association between diastolic blood pressure change and duloxetine treatment. Nominally significant within-gene association was fo...
Several post-hoc studies have shown that lack of early improvement reduces the chance of later response or remission. This post-hoc analysis evaluates different cut-off points of non-improvement at 4...
Abstract Objective: This post-hoc analysis was conducted to investigate if safety outcomes differed among race/ethnic subgroups of patients treated with duloxetine for chronic painful conditions. Rese...
Priorities for improving drug research, development and regulation.
Osteoporosis and treatments in Japan: management for preventing subsequent fractures.
Prevalent fractures are major contributors to an increased risk of subsequent fractures, particularly in people with osteoporosis. While many studies have been conducted to assess the incidence of fra...
Videos
Pink Martini - Lilly
This song is from the movie Shanghai Kiss. No copyright infringements intended. SONG: Lilly ARTIST: Pink Martini.
